CHGCF News and Press, Chugai Pharmaceutical From 10/24/22

Chugai Pharmaceutical press release ( OTCPK:CHGCF ): 9M GAAP EPS of ¥165.29. Revenue of ¥821.45B (+21.2% Y/Y). For further details see: Chugai Pharmaceutical reports 9M results

Morgan Stanley says that global obesity sales in 2030 could reach $54B, driven by Eli Lilly ( NYSE: LLY ) and Novo Nordisk’s ( NVO ) ( OTCPK:NONOF ), while other large-cap pharma players closely watch their dominance amid emerging data from new biotechs. Obesi...

Takeda Pharmaceutical will be able to deliver stellar growth during the next decade. China and emerging markets will be a key driver of growth. The current share price is very undervalued considering the long term growth prospects. For further details see: Takeda Pharmac...

AstraZeneca (NASDAQ:AZN) will pay $775M to Roche's (OTCQX:RHHBY) (OTCQX:RHHBF) unit Chugai Pharmaceutical (OTCPK:CHGCF) to resolve all patent disputes related to rare disease drug Ultomiris. AstraZeneca had inherited the rare disease drug Ultomiris after acquiring Alexion Pharmaceuticals...

Roche (OTCQX:RHHBY) is closing a patent infringement suit against AstraZeneca (NASDAQ:AZN) related to the rare disease medicine Ultomiris, Fierce Pharma reported. AstraZeneca had inherited the rare disease drug Ultomiris after acquiring Alexion Pharmaceuticals. Roche’s C...

Gilead’s (NASDAQ:GILD) COVID-19 therapy remdesivir has claimed the top spot, overtaking AbbVie’s (NYSE:ABBV) anti-inflammatory medication Humira in a list of drugs compiled by the purchasing group Vizient Inc, based on the spending of its member hospitals. From October...

Genentech, a member of the Roche Group (OTCQX:RHHBY) announces results from an interim analysis of the Phase III HAVEN 6 study, which show Hemlibra (emicizumab-kxwh) demonstrated a favorable safety profile and effective bleed control in people with moderate or mild hemophilia A without f...

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2021 Earnings Conference Call October 22, 2021 5:00 AM ET Company Participants Osamu Okuda - President & Chief Executive Officer Toshiaki Itagaki - Executive Vice President & Chief Financial Officer Tetsuya Yamaguchi - Senior Vice President, ...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: Chugai Pharmaceutical Co., Ltd. 2021 Q3 - Results - Earnings Call Presentation

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Total return for Harding Loevner International Equity Fund net of fees was 5.43% vs. MSCI All Country World ex-US ...